US Stock MarketDetailed Quotes
TRAW Traws Pharma
- 4.700
- -0.230-4.67%
Close Nov 19 16:00 ET
14.22MMarket Cap-34P/E (TTM)
4.920High4.700Low6.89KVolume4.830Open4.930Pre Close33.24KTurnover0.30%Turnover RatioLossP/E (Static)3.03MShares27.50052wk High-6.99P/B10.73MFloat Cap4.44052wk Low--Dividend TTM2.28MShs Float1751062.500Historical High--Div YieldTTM4.46%Amplitude4.440Historical Low4.821Avg Price1Lot Size
Traws Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -156.79%-11.48M | -119.42%-9.85M | 2.62%-4.42M | -10.05%-17.93M | -14.06%-4.43M | -14.59%-4.47M | -6.55%-4.49M | -5.75%-4.54M | 16.39%-16.29M | 8.93%-3.88M |
| Net income from continuing operations | -78.84%-8.48M | -2,797.48%-123.14M | 13.71%-4.98M | 0.08%-18.95M | 22.80%-4.18M | 12.21%-4.74M | -5.62%-4.25M | -40.10%-5.78M | -17.33%-18.96M | -44.00%-5.42M |
| Depreciation and amortization | -60.00%2K | 0.00%4K | 33.33%4K | 14.29%16K | 0.00%4K | 66.67%5K | 0.00%4K | 0.00%3K | 0.00%14K | 0.00%4K |
| Other non cash items | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -3,422.11%-3.35M | -781.43%-4.56M | -75.14%222K | -120.28%-301K | -148.42%-582K | -107.98%-95K | -18.85%-517K | 288.79%893K | 141.30%1.48M | 256.92%1.2M |
| -Change in receivables | -210,200.00%-2.1M | --0 | --0 | 1,200.00%11K | --0 | ---1K | --0 | 1,100.00%12K | -111.11%-1K | -200.00%-1K |
| -Change in prepaid assets | 135.89%375K | -122.45%-22K | 131.54%76K | -450.22%-1.26M | -113.11%-72K | -388.67%-1.05M | 111.02%98K | 3.98%-241K | -143.21%-229K | 62.91%549K |
| -Change in payables and accrued expense | -254.86%-1.56M | -702.51%-4.48M | -82.85%202K | -39.20%1.17M | -163.94%-454K | 15.07%1.01M | -208.98%-558K | 805.39%1.18M | 149.44%1.93M | 178.02%710K |
| -Change in other current assets | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --9K | --0 |
| -Change in other working capital | 0.00%-57K | 0.00%-57K | 0.00%-56K | 0.00%-226K | 0.00%-56K | 0.00%-57K | 0.00%-57K | 0.00%-56K | 0.00%-226K | 0.00%-56K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -156.79%-11.48M | -119.42%-9.85M | 2.62%-4.42M | -10.05%-17.93M | -14.06%-4.43M | -14.59%-4.47M | -6.55%-4.49M | -5.75%-4.54M | 16.39%-16.29M | 8.93%-3.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -14K | 0 | -14K | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---14K | --0 | ---- | ---- | ---- | --0 | --0 |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | ---14K | --0 | ---14K | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | ||||||||
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -43.20%16.89M | -52.10%16.39M | -46.28%20.82M | -29.62%38.76M | -40.76%25.24M | -36.11%29.73M | -32.59%34.22M | -29.62%38.76M | 189.46%55.07M | -28.23%42.61M |
| Current changes in cash | -155.99%-11.48M | 111.11%499K | 2.62%-4.42M | -10.14%-17.95M | -14.06%-4.43M | -14.95%-4.48M | -6.55%-4.49M | -5.75%-4.54M | -145.17%-16.29M | 9.67%-3.88M |
| Effect of exchange rate changes | --0 | -200.00%-3K | -216.67%-7K | 152.63%10K | -75.00%7K | 90.00%-2K | 95.00%-1K | 185.71%6K | 32.14%-19K | 450.00%28K |
| End cash Position | -78.57%5.41M | -43.20%16.89M | -52.10%16.39M | -46.28%20.82M | -46.28%20.82M | -40.76%25.24M | -36.11%29.73M | -32.59%34.22M | -29.62%38.76M | -29.62%38.76M |
| Free cash flow | -155.99%-11.48M | -119.42%-9.85M | 2.62%-4.42M | -10.14%-17.95M | -14.06%-4.43M | -14.95%-4.48M | -6.55%-4.49M | -5.75%-4.54M | 16.39%-16.29M | 8.93%-3.88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data